English   español  

Browsing by Author Galán-Moya, Eva María

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 21  next >
RightsPreviewIssue DateTitleAuthor(s)Type
openAccessactivity_BET-proteolysis_targeting_chimeric.pdf.jpg30-Aug-2019Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancerNoblejas-López, María del Mar; Nieto-Jiménez, Cristina; Burgos, Miguel; Gómez-Juárez, Mónica; Montero, Juan Carlos CSIC ORCID; Esparís-Ogando, Azucena CSIC ORCID ; Pandiella, Atanasio CSIC ORCID CVN ; Galán-Moya, Eva María; Ocaña, Albertoartículo
openAccessAntitumoral Activity of a CDK9_Noblejas_PV_Art2022.pdf.jpg2022Antitumoral activity of a CDK9 PROTAC compound in HER2-Positive breast cancerNoblejas-López, María del Mar; Gandullo-Sánchez, Lucía CSIC ORCID; Galán-Moya, Eva María; López-Rosa, Raquel; Tebar-García, David; Nieto-Jiménez, Cristina; Gómez-Juárez, Mónica; Burgos, Miguel; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Albertoartículo
openAccessCheckpoint Kinase 1_Nieto_PV_Art2021.pdf.jpg2021Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA-Damaging Agents and Overcomes Platinum Resistance in Basal-Like Breast CancerNieto-Jiménez, Cristina; Alcaraz-Sanabria, Ana; Martínez-Canales, Sandra; Corrales-Sánchez, Verónica; Montero, Juan Carlos CSIC ORCID; Burgos, Miguel; Nuncia-Cantarero, Miriam; Pandiella, Atanasio CSIC ORCID CVN ; Galán-Moya, Eva María; Ocaña, Albertoartículo
openAccessEvaluation_Noblejas_PV_Art2018.pdf.jpg28-Nov-2018Evaluation of transcriptionally regulated genes identifies NCOR1 in hormone receptor negative breast tumors and lung adenocarcinomas as a potential tumor suppressor geneNoblejas-López, María del Mar; Morcillo-Garcia, Sara; Nieto-Jiménez, Cristina; Nuncia-Cantarero, Miriam; Győrffy, Balázs; Galán-Moya, Eva María; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Albertoartículo
openAccessFunctional_Martinez_PV_Art2018.pdf.jpgMay-2018Functional transcriptomic annotation and protein–protein interaction analysis identify EZH2 and UBE2C as key upregulated proteins in ovarian cancerMartínez-Canales, Sandra; Rodas, Miguel López de; Nuncia-Cantarero, Miriam; Páez, Raquel; Amir, Eitan; Győrffy, Balázs; Pandiella, Atanasio CSIC ORCID CVN ; Galán-Moya, Eva María; Ocaña, Albertoartículo
openAccessGenetic_Morcillo_Garcia_Art2019.pdf.jpg16-Apr-2019Genetic mutational status of genes regulating epigenetics: Role of the histone methyltransferase KMT2D in triple negative breast tumorsMorcillo-Garcia, Sara; Noblejas-López, María del Mar; Nieto-Jiménez, Cristina; Pérez-Peña, Javier; Nuncia-Cantarero, Miriam; Győrffy, Balázs; Amir, Eitan; Pandiella, Atanasio CSIC ORCID CVN ; Galán-Moya, Eva María; Ocaña, Albertoartículo
openAccessGenomic Correlates of DNA_Cabañas_PV_Art2021.pdf.jpg2021Genomic correlates of dna damage in breast cancer subtypesCabañas Morafraile, Esther; Pérez-Peña, Javier; Fuentes-Antrás, Jesús; Manzano, Aranzazu CSIC ORCID ; Pérez-Segura, Pedro; Pandiella, Atanasio CSIC ORCID CVN ; Galán-Moya, Eva María; Ocaña, Albertoartículo
closedAccessaccesoRestringido.pdf.jpg2017Impact of availability of companion diagnostics on the clinical development of anticancer drugsTibau, Ariadna; Díez-González, Laura; Navarro, Beatriz; Galán-Moya, Eva María; Templeton, Arnoud J.; Seruga, Bostjan; Pandiella, Atanasio CSIC ORCID CVN ; Amir, Eitan; Ocaña, Albertoartículo
openAccessinhibitcance.pdf.jpg2020Inhibition of the mitotic kinase PLK1 overcomes therapeutic resistance to BET inhibitors in triple negative breast cancerNieto-Jiménez, Cristina; Galán-Moya, Eva María; Corrales-Sánchez, Verónica; Noblejas-López, María del Mar; Burgos, Miguel; Domingo, Beatriz; Montero, Juan Carlos CSIC ORCID; Gómez-Juárez, Mónica; Picazo-Martinez, Maria Granada; Esparís-Ogando, Azucena CSIC ORCID ; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Albertoartículo
openAccessMapping_Perez_Pena_Art2019.pdf.jpg2019Mapping Bromodomains in breast cancer and association with clinical outcomePérez-Peña, Javier; Páez, Raquel; Nieto-Jiménez, Cristina; Corrales-Sánchez, Verónica; Galán-Moya, Eva María; Pandiella, Atanasio CSIC ORCID CVN ; Győrffy, Balázs; Ocaña, Albertoartículo
openAccessMapping of Genomic_Fuentes_PV_Art2021.pdf.jpg2021Mapping of Genomic Vulnerabilities in the Post-Translational Ubiquitination, SUMOylation and Neddylation Machinery in Breast CancerFuentes-Antrás, Jesús; Alcaraz-Sanabria, Ana; Cabañas Morafraile, Esther; Noblejas-López, María del Mar; Galán-Moya, Eva María; Baliu-Piqué, Mariona; López-Cade, Igor; García-Barberán, Vanesa; Pérez-Segura, Pedro; Manzano, Aranzazu CSIC ORCID ; Pandiella, Atanasio CSIC ORCID CVN ; Győrffy, Balázs; Ocaña, Albertoartículo
openAccessMZ1 co-operates_Noblejas_López_PV_Art2021.pdf.jpg2021MZ1 co-operates with trastuzumab in HER2 positive breast cancerNoblejas-López, María del Mar; Nieto-Jiménez, Cristina; Galán-Moya, Eva María; Tebar-García, David; Pandiella, Atanasio CSIC ORCID CVN ; Burgos, Miguel; Ocaña, Albertoartículo
openAccesspharmacance.pdf.jpg2020Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple‐negative breast cancerCorrales-Sánchez, Verónica; Noblejas-López, María del Mar; Nieto-Jiménez, Cristina; Pérez-Peña, Javier; Montero, Juan Carlos CSIC ORCID; Burgos, Miguel; Galán-Moya, Eva María; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Albertoartículo
openAccessPrognostic value of the immune_Burgos_PV_Art2022.pdf.jpg19-Jan-2022Prognostic value of the immune target CEACAM6 in cancer: a meta-analysisBurgos, Miguel; Cavero-Redondo, Iván; Álvarez-Bueno, Celia; Galán-Moya, Eva María; Pandiella, Atanasio CSIC ORCID CVN ; Amir, Eitan; Ocaña, Albertoartículo
openAccess21-Jan-2022sj-docx-1-tam-10.1177_17588359211072621 – Supplemental material for Prognostic value of the immune target CEACAM6 in cancer: a meta-analysis [Dataset]Burgos, Miguel; Cavero-Redondo, Iván; Álvarez-Bueno, Celia; Galán-Moya, Eva María; Pandiella, Atanasio CSIC ORCID CVN ; Amir, Eitan; Ocaña, Albertodataset
openAccess21-Jan-2022sj-docx-2-tam-10.1177_17588359211072621 – Supplemental material for Prognostic value of the immune target CEACAM6 in cancer a meta-analysis [Dataset]Burgos, Miguel; Cavero-Redondo, Iván; Álvarez-Bueno, Celia; Galán-Moya, Eva María; Pandiella, Atanasio CSIC ORCID CVN ; Amir, Eitan; Ocaña, Albertodataset
openAccesssj-jpg-1-tam-10.1177_17588359211072621.jpg.jpg21-Jan-2022sj-jpg-1-tam-10.1177_17588359211072621 – Supplemental material for Prognostic value of the immune target CEACAM6 in cancer: a meta-analysis [Dataset]Burgos, Miguel; Cavero-Redondo, Iván; Álvarez-Bueno, Celia; Galán-Moya, Eva María; Pandiella, Atanasio CSIC ORCID CVN ; Amir, Eitan; Ocaña, Albertodataset
openAccesssj-jpg-2-tam-10.1177_17588359211072621.jpg.jpg21-Jan-2022sj-jpg-2-tam-10.1177_17588359211072621 – Supplemental material for Prognostic value of the immune target CEACAM6 in cancer: a meta-analysis [Dataset]Burgos, Miguel; Cavero-Redondo, Iván; Álvarez-Bueno, Celia; Galán-Moya, Eva María; Pandiella, Atanasio CSIC ORCID CVN ; Amir, Eitan; Ocaña, Albertodataset
openAccesssyntcanc.pdf.jpg2017Synthetic lethality interaction between aurora kinases and CHEK1 inhibitors in ovarian cancerAlcaraz-Sanabria, Ana; Nieto-Jiménez, Cristina; Corrales-Sánchez, Verónica; Serrano-Oviedo, Leticia; Andrés-Pretel, Fernando; Montero, Juan Carlos CSIC ORCID; Burgos, Miguel; Llopis, Juan; Galán-Moya, Eva María; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Albertoartículo
openAccesstargetinhibi.pdf.jpg2017Targeting basal-like breast tumors with bromodomain and extraterminal domain (BET) and polo-like kinase inhibitorsNieto-Jiménez, Cristina; Alcaraz-Sanabria, Ana; Pérez-Peña, Javier; Corrales-Sánchez, Verónica; Serrano-Heras, Gemma CSIC ORCID; Galán-Moya, Eva María; Serrano-Oviedo, Leticia; Montero, Juan Carlos CSIC ORCID; Burgos, Miguel; Llopis, Juan; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Albertoartículo